BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19528430)

  • 1. Cutaneous lymphomas: what can we learn from location?
    Grange F; Antonicelli F
    Arch Dermatol; 2009 Jun; 145(6):710-2. PubMed ID: 19528430
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
    Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
    J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T-cell lymphoma.
    Poligone B; Wilson LD; Subtil A; Heald P
    Arch Dermatol; 2009 Jun; 145(6):677-82. PubMed ID: 19528423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized cutaneous T cell lymphoma presenting as disfiguring facial lesions.
    Kaliyadan F; Jayasree MG; Unni M; Neeraj S
    Dermatol Online J; 2009 Nov; 15(11):14. PubMed ID: 19951650
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
    Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
    J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphoma.
    Shapiro M; Rook AH; Lehrer MS; Junkins-Hopkins JM; French LE; Vittorio CC
    J Am Acad Dermatol; 2002 Dec; 47(6):956-61. PubMed ID: 12451388
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type.
    Massone C; Fink-Puches R; Wolf I; Zalaudek I; Cerroni L
    J Am Acad Dermatol; 2015 Jun; 72(6):1016-20. PubMed ID: 25824272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing clinical outcomes in cutaneous T-cell lymphoma.
    Zackheim HS; Koh HK; Weinstock MA
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1021-9. PubMed ID: 8522482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant cutaneous T-cell lymphomas.
    Lok C; Viseux V; Denoeux JP; Bagot M
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):137-45. PubMed ID: 16046144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the primary cutaneous lymphomas.
    Prince HM; McCormack C; Ryan G; O'Keefe R; Seymour JF; Baker C
    Australas J Dermatol; 2003 Nov; 44(4):227-40; quiz 241-2. PubMed ID: 14616487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial swelling: an atypical presentation of cutaneous lymphoma.
    Lee WJ; Moon IJ; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    Int J Dermatol; 2016 Aug; 55(8):e440-6. PubMed ID: 26945567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of primary cutaneous CD4
    Yuan Z; Grass GD; Robinson TJ; Kim S
    J Am Acad Dermatol; 2018 Oct; 79(4):772-774. PubMed ID: 29857014
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging.
    Battistella M; Sallé de Chou C; de Bazelaire C; Cayuela JM; de Kerviler E; Bagot M; Janin A
    Br J Dermatol; 2016 Dec; 175(6):1397-1400. PubMed ID: 27377879
    [No Abstract]   [Full Text] [Related]  

  • 16. Memorials and mandates for cutaneous lymphomas.
    Heald PW
    Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary cutaneous B-cell lymphoma: report of eight cases and review of the literature.
    Vural F; Saydam G; Cagirgan S; Ertekin B; Hekimgil M; Unal I; Soydan S; Tombuloglu M
    Int J Dermatol; 2008 Jul; 47(7):675-80. PubMed ID: 18613872
    [No Abstract]   [Full Text] [Related]  

  • 18. Is cutaneous T-cell lymphoma curable?
    Koh HK; Jacobson JO; Foss F; Lew RA
    Arch Dermatol; 1995 Sep; 131(9):1081-2. PubMed ID: 7661616
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous lymphomas other than mycosis fungoides.
    Joly P; Thomine E; Lauret P
    Semin Dermatol; 1994 Sep; 13(3):172-9. PubMed ID: 7986685
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary cutaneous T-cell lymphoma, unspecified, exhibiting an aggressive clinical course and a cytotoxic phenotype.
    Yamamoto M; Nakada T; Iijima M
    Int J Dermatol; 2008 Jul; 47(7):720-2. PubMed ID: 18613882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.